Acceleron Pharma

412 articles about Acceleron Pharma

• Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in Preclinical Studies

  5/14/2007

• Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Management

  4/25/2007

• Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing

  3/29/2007

• Acceleron Pharma to Present at the Cowen 27th Annual Health Care Conference

  3/7/2007

• Acceleron Pharma To Present At The Rodman & Renshaw 8th Annual Healthcare Conference

  11/3/2006

• Acceleron Pharma To Present At The MBC's MASS Opportunities Conference

  10/30/2006

• Acceleron Pharma Presents ACE-011 Preclinical Data Demonstrating Both Anabolic And Anti-Resorptive Properties; Novel Approach Represents Significant Advance For The Treatment Of Bone Loss

  9/18/2006

• Acceleron Pharma To Present ACE-011 Preclinical Data At The Annual Meeting Of The American Society For Bone And Mineral Research; Preclinical Data Demonstrates Dual Activity Of ACE-011

  9/12/2006

• Acceleron Pharma Closes $30M Series B Financing

  8/2/2006

• Acceleron Pharma Initiates Phase 1 Clinical Trial Of ACE-011, A Novel Treatment For Bone Loss

  6/21/2006

• Acceleron Pharma Appoints Matthew L. Sherman, M.D. As Chief Medical Officer

  5/16/2006

• Hercules Technology Growth Capital Provides $8.0M Financing To Acceleron Pharma, A Leading Biopharmaceutical Company Focused On Metabolic And Musculosketal Therapeutics

  1/5/2006